Total trials
67
Active
20
Phase 3
1
Total enrollment
14,063
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Down-titration | — | — | — | — | — | 1 | |
| Continuation of guideline-directed heart failure therapy | — | — | — | — | — | 1 | |
| Dexamethasone | — | — | — | — | — | 1 | |
| Dexmedetomidine | — | — | — | — | — | 1 | |
| Ferric Carboxymaltose | — | — | — | — | — | 1 | |
| Sodium Chloride (NaCl) 0.9 % | — | — | — | — | — | 1 | |
| 0.25% ropivacaine | — | — | — | — | — | 1 | |
| 0.5% ropivacaine | — | — | — | — | — | 1 | |
| 1% ropivacaine | — | — | — | — | — | 1 |
Next readouts
- 2026-04-01
- 2027-02
- 2027-05-01
- 2028-07
- 2028-09
Top conditions
- Atrial Fibrillation5
- Heart Failure3
- NAFLD3
- Acute Decompensated Heart Failure2
- Ischemic Stroke2
- Postoperative Fatigue2
- Preterm Birth2
- Non-Alcoholic Fatty Liver Disease2
Frequently asked questions about Ziekenhuis Oost-Limburg
- How many clinical trials does Ziekenhuis Oost-Limburg have on ClinicalTrials.gov?
- Ziekenhuis Oost-Limburg is listed as the lead sponsor on 67 clinical trials in ClinicalTrials.gov, 20 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ziekenhuis Oost-Limburg's trials are in Phase 3?
- 1 of Ziekenhuis Oost-Limburg's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does Ziekenhuis Oost-Limburg focus on?
- Ziekenhuis Oost-Limburg's most-studied conditions on ClinicalTrials.gov are Atrial Fibrillation, Heart Failure, NAFLD, Acute Decompensated Heart Failure, Ischemic Stroke.
- When are Ziekenhuis Oost-Limburg's next clinical trial readouts?
- Ziekenhuis Oost-Limburg has 5 upcoming primary-completion readouts tracked here; the soonest is “The Effect of Nocturnal Dexmedetomidine on Postoperative Sleep Quality and Fatigue After Major Surgery in Elderly Patients: DEXSLEEP Study”, expected around 2026-04-01.